KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Non-Current Assets (2016 - 2025)

Elevance Health (ELV) has disclosed Non-Current Assets for 17 consecutive years, with $59.0 billion as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Assets rose 9.84% to $59.0 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $234.1 billion, a 14.63% increase, with the full-year FY2024 number at $57.9 billion, up 18.5% from a year prior.
  • Non-Current Assets was $59.0 billion for Q3 2025 at Elevance Health, up from $58.6 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $59.0 billion in Q3 2025 to a low of $41.2 billion in Q1 2021.
  • A 5-year average of $50.2 billion and a median of $49.2 billion in 2023 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: increased 0.11% in 2021, then rose 18.5% in 2024.
  • Elevance Health's Non-Current Assets stood at $46.3 billion in 2021, then grew by 1.74% to $47.1 billion in 2022, then grew by 3.74% to $48.9 billion in 2023, then increased by 18.5% to $57.9 billion in 2024, then grew by 1.77% to $59.0 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Non-Current Assets are $59.0 billion (Q3 2025), $58.6 billion (Q2 2025), and $58.6 billion (Q1 2025).